Genetic testing for atherosclerosis risk: inevitability or pipe dream?

Area of Science:

• Genetics
• Cardiovascular Disease
• Genomic Medicine

Background:

• Family history is a known risk factor for coronary artery disease (CAD).
• Identifying genetic markers for CAD risk has been challenging.
• A significant association between CAD and chromosome 9p21 was reported in 2007.

Purpose of the Study:

• To examine the feasibility of incorporating DNA tests into CAD risk prediction algorithms.
• To assess the clinical utility of the 9p21 genetic association for CAD risk assessment.

Main Methods:

• Review of genome-wide association studies (GWAS).
• Analysis of the 9p21 genetic locus and its association with CAD.
• Evaluation of the effect size and prevalence of the high-risk genotype.

Main Results:

• A strong association exists between CAD and a specific region on chromosome 9p21.
• The high-risk genotype is present in up to 30% of individuals.
• The reported odds ratio for CAD associated with this genotype is modest (approximately 1.3).

Conclusions:

• The 9p21 genetic association holds potential for clinical genetic testing in CAD risk calculation.
• Further research into the mechanistic basis of the 9p21 association is needed.
• Understanding this genetic link may offer new insights into CAD progression, prevention, and treatment.